Data gathered: May 17
Alternative Data for Zoetis
About Zoetis
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 65 years of experience in animal health, Zoetis discovers, develops, manufactures and commercializes medicines, vaccines and diagnostic products, which are complemented by biodevices, genetic tests and precision livestock farming.
| Price | $173.71 |
| Target Price | Sign up |
| Volume | 1,690,000 |
| Market Cap | $79.1B |
| Year Range | $145.54 - $199.38 |
| Dividend Yield | 1% |
| PE Ratio | 33.32 |
| Revenue per Employee | $632,899 |
| Industry | Pet Care |
In the news
Zoetis (ZTS) Stock Declines Amid Concerns Over Arthritis Drugs Impacting Pets – Hagens BermanMay 16 - GlobeNewswire |
|
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zoetis Inc. - ZTSMay 16 - Finnhub |
|
 |
Zoetis to Participate in the Stifel 2024 Jaws and Paws ConferenceMay 15 - Yahoo |
 |
Zoetis Named a Top Company for DE&I by Fair360 (Formerly DiversityInc.)May 14 - Marketscreener.com |
See Which Of The Latest 13F Filers Holds ZoetisMay 13 - Preferred Stock Channel |
|
Global Bovine Respiratory Disease Treatment Strategic Business Report 2024-2030 Featuring Bayer, Bimeda, Boehringer Ingelheim, Ceva Sante Animale, Elanco, Merck, Vetoquinol, Virbac, & ZoetisMay 13 - GlobeNewswire |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 2.19B | 1.25B | 943M | 599M | 849M | 1.380 |
| Q4 '23 | 2.21B | 1.36B | 852M | 525M | 756M | 1.240 |
| Q3 '23 | 2.15B | 1.22B | 930M | 596M | 822M | 1.360 |
| Q2 '23 | 2.18B | 1.22B | 959M | 671M | 979M | 1.410 |
| Q1 '23 | 2B | 1.16B | 839M | 552M | 808M | 1.310 |
Insider Transactions View All
| Lagano Roxanne filed to sell 14,800 shares at $151.2. April 18 '24 |
| Lagano Roxanne filed to sell 15,723 shares at $173.3. March 18 '24 |
| Reed Willie M filed to sell 9,994 shares at $182.7. March 12 '24 |
| Lagano Roxanne filed to sell 16,646 shares at $187.3. February 21 '24 |
| PECK KRISTIN C filed to sell 79,366 shares at $187.2. February 21 '24 |
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
| Rohit Khanna Democrat |
May 6, 24 | Buy | $1K - $15K |
| Markwayne Mullin Republican |
May 2, 24 | Sell | $1K - $15K |
Read more about Zoetis (ZTS) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, app downloads, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Zoetis?
The Market Cap of Zoetis is $79.1B.
What is Zoetis' PE Ratio?
As of today, Zoetis' PE (Price to Earnings) ratio is 33.32.
How Many People Work at Zoetis?
As of our latest update, Zoetis employed approximately 13,800 people worldwide. However, it's important to note that Zoetis' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Zoetis' revenue per employee?
$632,899. To calculate Zoetis' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Zoetis?
Currently, the price of one share of Zoetis stock is $173.71.
How can I analyze the ZTS stock price chart for investment decisions?
The ZTS stock price chart above provides a comprehensive visual representation of Zoetis' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Zoetis shares. Our platform offers an up-to-date ZTS stock price chart, along with technical data analysis and alternative data insights.
Does ZTS offer dividends to its shareholders?
Yes, Zoetis (ZTS) offers dividends to its shareholders, with a dividend yield of 1%. This dividend yield represents Zoetis' commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Zoetis in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.
What are some of the similar stocks of Zoetis?
Some of the similar stocks of Zoetis are Chewy, Petco, PetMeds, BARK, and Chewy.
.